Search Results - DISEASES::Neoplasms::Neoplasms by Site::Soft Tissue Neoplasms

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries by Berrington de Gonzalez, A, Curtis, R E, Gilbert, E, Berg, C D, Smith, S A, Stovall, M, Ron, E

“…Background: Radiotherapy for breast cancer reduces disease recurrence and breast cancer mortality…”
Get full text

Predictors of Progression-Free Survival and Local Tumor Control after Percutaneous Thermal Ablation of Oligometastatic Breast Cancer: Retrospective Study by Ridouani, Fourat, Solomon, Stephen B, Bryce, Yolanda, Bromberg, Jacqueline F, Sofocleous, Constantinos T, Deipolyi, Amy R

“…), and bone/soft tissue (n = 4) metastases. Mean tumor diameter was 18 ± 15 mm (range, 6-50 mm). Ablations were performed to eradicate all evident sites of disease…”
Get more information

Angiomatoid fibrous histiocytoma: unusual sites and unusual morphology by Chen, Gang, Folpe, Andrew L, Colby, Thomas V, Sittampalam, Kesavan, Patey, Martine, Chen, Ming-Guang, Chan, John K C

“…Angiomatoid fibrous histiocytoma is a soft tissue neoplasm of low malignant potential, typically occurring in the superficial soft tissues of the extremities in children and young adults…”
Get full text

Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved? by Casey, Dana L, Pitter, Ken L, Kushner, Brian H, Cheung, Nai-Kong V, Modak, Shakeel, LaQuaglia, Michael P, Wolden, Suzanne L

“…) both to the primary site and to sites of metastatic disease that persist after induction chemotherapy…”
Get more information

Treatment and outcomes in pediatric inflammatory myofibroblastic tumors – A systematic review of published studies by Raitio, Arimatias, Losty, Paul D.

“…Inflammatory myofibroblastic tumor (IMT) is a soft tissue neoplasm which can be locally invasive, recur, or in rare cases metastasize…”
Get full text

A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations by Brown, Aaron P, Neeley, E Shannon, Werner, Theresa, Soisson, Andrew Patrick, Burt, Randall W, Gaffney, David K

“… Standardized incidence ratios were calculated (observed/expected [O/E]) for SPM sites. Median follow…”
Get more information

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents by Usmani, S. Z., Heuck, C., Mitchell, A., Szymonifka, J., Nair, B., Hoering, A., Alsayed, Y., Waheed, S., Haider, S., Restrepo, A., Van Rhee, F., Crowley, J., Barlogie, B.

“… The most common sites for extramedullary disease at diagnosis were skin and soft tissue…”
Get full text

Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature by Folpe, Andrew L, Mentzel, Thomas, Lehr, Hans-Anton, Fisher, Cyril, Balzer, Bonnie L, Weiss, Sharon W

“…, we present our experience with 26 PEComas of soft tissue and the gynecologic tract, the largest series to date…”
Get more information

Distinctive Nested Glomoid Neoplasm: Clinicopathologic Analysis of 20 Cases of a Mesenchymal Neoplasm With Frequent GLI1 Alterations and Indolent Behavior by Papke, Jr, David J, Dickson, Brendan C, Oliveira, Andre M, Sholl, Lynette M, Fletcher, Christopher D M

“…Recently, it has been recognized that a subset of primary soft tissue neoplasms with GLI1 gene alterations exhibit nested architecture and can mimic glomus tumors or well-differentiated neuroendocrine tumors…”
Get more information

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting by Park, Julie R, Bagatell, Rochelle, Cohn, Susan L, Pearson, Andrew D, Villablanca, Judith G, Berthold, Frank, Burchill, Susan, Boubaker, Ariane, McHugh, Kieran, Nuchtern, Jed G, London, Wendy B, Seibel, Nita L, Lindwasser, O Wolf, Maris, John M, Brock, Penelope, Schleiermacher, Gudrun, Ladenstein, Ruth, Matthay, Katherine K, Valteau-Couanet, Dominique

“…) to assess treatment response in children with neuroblastoma. However, this system requires modification to incorporate modern imaging techniques and new methods for quantifying bone marrow disease that were not previously widely available…”
Get more information

Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases by Greco, Carlo, Zelefsky, Michael J, Lovelock, Michael, Fuks, Zvi, Hunt, Margie, Rosenzweig, Kenneth, Zatcky, Joan, Kim, Balem, Yamada, Yoshiya

“…) to extracranial metastatic sites. A total of 126 metastases in 103 patients were treated with SD-IGRT to prescription doses of 18-24 Gy (median, 24 Gy…”
Get more information

Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas by Vogt, Markus, Munding, Johanna, Grüner, Martha, Liffers, Sven-Thorsten, Verdoodt, Berlinda, Hauk, Jennifer, Steinstraesser, Lars, Tannapfel, Andrea, Hermeking, Heiko

“… lines of diverse origin. Here we analyzed the methylation status of miR-34a and miR-34b/c in additional primary tumors of divergent sites…”
Get full text

Extra-abdominal and intra-abdominal FET::CREM fusion mesenchymal neoplasms: comparative clinicopathological study of 9 new cases further supporting a distinct potentially aggressive sarcoma and report of novel sites by Agaimy, Abbas, Blakely, Morgan, Breimer, Gerben E., Hölsken, Annett, Koppes, Sjors A., Meidenbauer, Norbert, Rijken, Johannes A., Schad, Arno, Simon, Adrian G., Stoehr, Robert, Bishop, Justin A., Din, Nasir Ud

“… years (median, 34). Extra-abdominal tumors originated in the head and neck (2 sinonasal, 1 orbital) and soft tissues…”
Get full text

Metastasizing "benign" cutaneous fibrous histiocytoma: a clinicopathologic analysis of 16 cases by Doyle, Leona A, Fletcher, Christopher D M

“… The primary site in 1 case was unknown. Fifteen primary tumors available for review involved the dermis…”
Get more information

Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis by Miettinen, Markku

“… Soft tissue smooth muscle tumors with both atypia and mitotic activity are generally diagnosed leiomyosarcomas acknowledging potential for metastasis…”
Get full text

Doxorubicin–Trabectedin with Trabectedin Maintenance in Leiomyosarcoma by Pautier, Patricia, Italiano, Antoine, Piperno-Neumann, Sophie, Chevreau, Christine, Penel, Nicolas, Firmin, Nelly, Boudou-Rouquette, Pascaline, Bertucci, François, Lebrun-Ly, Valérie, Ray-Coquard, Isabelle, Kalbacher, Elsa, Bompas, Emmanuelle, Collard, Olivier, Isambert, Nicolas, Guillemet, Cécile, Rios, Maria, Le Cesne, Axel, Balleyguier, Corinne, Archambaud, Baptiste, Duffaud, Florence

“…Among patients with leiomyosarcoma, a combination of doxorubicin and trabectedin with prolonged trabectedin maintenance therapy led to longer overall survival…”
Get full text

Predictors of Survival and Recurrence in Primary Leiomyosarcoma by Gladdy, Rebecca A., Qin, Li-Xuan, Moraco, Nicole, Agaram, Narasimhan P., Brennan, Murray F., Singer, Samuel

“…Background Leiomyosarcoma is a soft tissue sarcoma whose outcome has historically been confounded by the inclusion of gastrointestinal stromal tumors…”
Get full text

Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma by Parsai, Shireen, Sedor, Geoffrey, Smile, Timothy D, Scott, Jacob, Ochocki, Allison, Vassil, Nicole, Zahler, Stacey, Angelov, Lilyana, Chao, Samuel T, Qi, Peng, Anderson, Peter, Murphy, Erin S

“… Median patient age was 17.9 years at treatment. Sixteen patients were treated with SBRT to >1 site of disease…”
Get more information

The concept of curative margin in surgery for bone and soft tissue sarcoma by Kawaguchi, Noriyoshi, Ahmed, Adel Refaat, Matsumoto, Seiichi, Manabe, Jun, Matsushita, Yasushi

“…To clarify the safety margin in excision of bone and soft tissue sarcomas, a new evaluation method for surgical margins was drafted by the Bone and Soft Tissue Committee of the Japanese Orthopaedic Association in 1989…”
Get more information

Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials by D'Angelo, Sandra P, Mahoney, Michelle R, Van Tine, Brian A, Atkins, James, Milhem, Mohammed M, Jahagirdar, Balkrishna N, Antonescu, Cristina R, Horvath, Elise, Tap, William D, Schwartz, Gary K, Streicher, Howard

“… measurable lesion by Response Evaluation Criteria In Solid Tumors (RECIST) 1.1, evidence of metastatic, locally advanced or unresectable disease, an ECOG performance status of 0…”
Get full text